📌 ANÁLISIS TÉCNICO de Acciones del Ibex (Acciona, Acs, Bbva, Acerinox, Fluidra, Endesa, Grifols...)
1 extracted signal · 0 resolved · 1 still active
Daniel Pernas - DPStradingIndependent analyst profile- Source published
- 19 Oct 2026, 07:30 UTC
- Recorded by Tahlil Plus
- 31 Oct 2026, 07:31 UTC
AI-generated source summary
The analysis covers several Spanish stocks, including CIRSA, ACS, BBVA, ELE, GRF, FERROVIAL, FLUIDRA, and CELNEX. Technical analysis is applied using weekly charts, focusing on support and resistance levels, moving averages (200-week and 200-day), and chart patterns like triangles and double tops/bottoms. For CIRSA, a bullish outlook is presented with a target of 17.34, invalidated below 16.82, despite a current bearish trend. ACS shows potential for an upward move towards 63.72, invalidated below 45.0, with a bullish prediction despite a current bearish trend. BBVA and ELE are presented with bullish predictions and targets, with fail bounds set below current prices. GRF and FERROVIAL show bearish trends and are considered to have resistance at key levels, with no immediate bullish entry signal. FLUIDRA is in a downtrend with resistance at 17.64, and CELNEX is in a descending wedge pattern suggesting a potential bullish breakout above 29.82. The overall market sentiment leans towards caution due to the numerous resistance levels and downward trends observed in several key stocks.
AI-generated summary based on the source content.
Signal outcomes at a glance
Tracking LiveSignals in this source
Evidence and evaluation progress
- Original source published
The analyst published the original source item.
- Source recorded by Tahlil Plus
The public source was preserved as the evidence record for this case.
- Market predictions extracted
1 eligible signal linked to this case.
- Source processing completed
Source analysis and structured extraction completed.
- Outcome tracking started
Tahlil Plus began monitoring the extracted predictions.
- Live evaluation in progress
1 signal remains active.
Daniel Pernas - DPStrading
Platform-wide history, separate from this source evaluation.
Tahlil Plus independently records and evaluates public market predictions. Extraction may be AI-assisted and results follow the Tahlil Plus methodology. This information is not financial advice.